Product Information

DOXAZOSIN MESYLATE 1 MG TAB is a generic product labeled by Accord Healthcare Inc., priced at $0.0772 per EA under NDC 16729021117. Its NADAC has been published 528 times since Jul 13, 2016.

FDA first approved this application on Jun 11, 2014. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

The High Outlier badge above means this manufacturer's average price in the Doxazosin market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.

DOXAZOSIN MESYLATE 1 MG TAB

Doxazosin
$0.0772per EA
High Outlier

Strength

1 mg/1

NDC

16729021117

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Effective Date

8/19/2026

Active Ingredients

DOXAZOSIN MESYLATE

Approval Type

Generic (ANDA)

FDA Application

ANDA202824

FDA Approved

6/11/2014

TE Code

AB

On Market Since

3/4/2015

Pharmacological Classes

Adrenergic alpha-Antagonists
alpha-Adrenergic Blocker

Price Statistics

The NADAC for DOXAZOSIN MESYLATE 1 MG TAB has been published 528 times since Jul 13, 2016, and over the history we have for it it has declined 81.6%. The table below summarizes its recorded NADAC range and movement.

Current price$0.0772 per EA
All-time high$0.4558 (Sep 14, 2016)
All-time low$0.0619 (Aug 18, 2021)
52-week high$0.0856
52-week low$0.0763
Median price$0.0986
Average price$0.1554
Largest weekly change+60.3% (Sep 22, 2021)
Weeks tracked528
Tracking sinceJul 13, 2016

Price History

1W

N/A

1M

N/A

3M

+1.2%

6M

-4.6%

1Y

-7.9%

3Y

-2.6%

5Y

-22.1%

All

-81.6%

Last surveyed Aug 19, 2026 — this NDC no longer appears in the current weekly NADAC file.

Generic Alternatives

The matcher finds 8 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 3% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of DOXAZOSIN MESYLATE 1 MG TAB?

The current National Average Drug Acquisition Cost (NADAC) for DOXAZOSIN MESYLATE 1 MG TAB, manufactured by Accord Healthcare Inc., is $0.0772 per EA (NDC 16729021117), effective Aug 19, 2026.

How has the price of DOXAZOSIN MESYLATE 1 MG TAB changed over time?

Over the history we have for it, the NADAC for DOXAZOSIN MESYLATE 1 MG TAB has declined 81.6%. It has been tracked across 528 weekly CMS publications since Jul 13, 2016.

What are the highest and lowest recorded NADAC prices for DOXAZOSIN MESYLATE 1 MG TAB?

Since Jul 13, 2016, the NADAC for DOXAZOSIN MESYLATE 1 MG TAB has ranged from a low of $0.0619 (Aug 18, 2021) to a high of $0.4558 (Sep 14, 2016), with a median of $0.0986 per EA.

Are there cheaper alternatives to DOXAZOSIN MESYLATE 1 MG TAB?

Yes. 8 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, DOXAZOSIN MESYLATE 1 MG TAB, is $0.0752 per EA — about 3% below DOXAZOSIN MESYLATE 1 MG TAB.

Who manufactures DOXAZOSIN MESYLATE 1 MG TAB?

DOXAZOSIN MESYLATE 1 MG TAB (NDC 16729021117) is labeled by Accord Healthcare Inc., and CMS classifies it as a generic product.